A Silicon Valley-based CEO has shifted her focus from biotechnology to Assyrian arts and is producing an opera to keep her Assyrian heritage alive.
Nora Lacey, CEO of biotech company Cell Marque Corporation, told EpochTV’s “Bay Area Innovators” program about her journey and decision.
Lacey was always interested in science and wanted to be on the cutting edge of research, with a focus in molecular biology. Her company was producing products that were meant to detect cancer, so working to save lives became meaningful. And she is proud of what she has done.
Lacey sold her business in 2014 and retired at age 55. Her passion is in art, and she knew she wanted to do philanthropy….